Most Clicked StoriesMore >
Generic-drug makers say big drugmakers restrict access to samples
FDLI SmartBrief | May 23, 2012
The Senate and the Federal Trade Commission are examining generic-drug makers' assertions that some drugmakers prevent development of generic drugs by exploiting FDA-imposed restrictions on distribution. Generics makers need to test their versions against samples of branded drugs, but they say the drugmakers are refusing to sell to them. Washington Post, The (05/22)
Senate adds 10 amendments to user fee bill
FDLI SmartBrief | May 25, 2012
Senate rejects drug reimportation, supplement registry
FDLI SmartBrief | May 29, 2012
Senate OKs FDA plan for review fees from drug and device firms
FDLI SmartBrief | May 25, 2012
Dietary supplement faces class action in Calif.
FDLI SmartBrief | May 23, 2012
FDA panel doesn't endorse J&J and Bayer's Xarelto for ACS
FDLI SmartBrief | May 24, 2012
Senator's egg bill would require colony cages for hens
FDLI SmartBrief | May 29, 2012
Shanghai Pharma reportedly being investigated for buyouts
FDLI SmartBrief | May 24, 2012
Improve Your Mental Toughness in 2 Minutes
FDLI SmartBrief | May 29, 2012
Bill aims to better monitor drug wholesalers
FDLI SmartBrief | May 23, 2012
Find FDLI SmartBrief Issues by Date:
FDLI News
More >
Introduction to Medical Device Law in Palo Alto, Calif., next week
FDLI SmartBrief | May 29, 2012
Hot Topic: "Should surgeons be encouraged to take an active role in the implantable medical device supply chain through physician-owned entities?"
FDLI SmartBrief | May 29, 2012
FDLI conferences you won’t want to miss -- members save 20% on registration
FDLI SmartBrief | May 25, 2012
FDLI's Advertising and Promotion Conference -- call for sessions
FDLI SmartBrief | May 24, 2012
Discover the value of FDLI membership -- join today
FDLI SmartBrief | May 23, 2012
Sign up for FDLI SmartBrief
Recent Poll view more polls